Canada markets closed
  • S&P/TSX

    20,138.35
    +88.88 (+0.44%)
     
  • S&P 500

    4,247.44
    +8.26 (+0.19%)
     
  • DOW

    34,479.60
    +13.36 (+0.04%)
     
  • CAD/USD

    0.8228
    -0.0041 (-0.50%)
     
  • CRUDE OIL

    70.78
    +0.49 (+0.70%)
     
  • BTC-CAD

    43,169.12
    -2,334.40 (-5.13%)
     
  • CMC Crypto 200

    924.19
    -17.62 (-1.87%)
     
  • GOLD FUTURES

    1,879.50
    -16.90 (-0.89%)
     
  • RUSSELL 2000

    2,335.81
    +24.40 (+1.06%)
     
  • 10-Yr Bond

    1.4620
    +0.0030 (+0.21%)
     
  • NASDAQ

    14,069.42
    +49.09 (+0.35%)
     
  • VOLATILITY

    15.65
    -0.45 (-2.80%)
     
  • FTSE

    7,134.06
    +45.88 (+0.65%)
     
  • NIKKEI 225

    28,948.73
    -9.83 (-0.03%)
     
  • CAD/EUR

    0.6792
    +0.0003 (+0.04%)
     

Biomarin Pharmaceutical Inc (BMRN) CEO Jean Jacques Bienaime Sold $585,060 of Shares

·2 min read

- By insider

CEO of Biomarin Pharmaceutical Inc (30-Year Financial, Insider Trades) Jean Jacques Bienaime (insider trades) sold 7,000 shares of BMRN on 02/19/2021 at an average price of $83.58 a share. The total sale was $585,060.


Biomarin Pharmaceutical Inc is on rare-disease therapies. It develops and commercializes pharmaceuticals for serious diseases and medical conditions. Biomarin Pharmaceutical Inc has a market cap of $14.71 billion; its shares were traded at around $81.060000 with a P/E ratio of 18.54 and P/S ratio of 8.11. GuruFocus has detected 2 severe warning signs with Biomarin Pharmaceutical Inc. .

CEO Recent Trades:

  • CEO Jean Jacques Bienaime sold 7,000 shares of BMRN stock on 02/19/2021 at the average price of $83.58. The price of the stock has decreased by 3.02% since.

  • CEO Jean Jacques Bienaime sold 7,000 shares of BMRN stock on 02/18/2021 at the average price of $85.08. The price of the stock has decreased by 4.72% since.

  • CEO Jean Jacques Bienaime sold 8,000 shares of BMRN stock on 02/17/2021 at the average price of $84.54. The price of the stock has decreased by 4.12% since.

  • CEO Jean Jacques Bienaime sold 16,667 shares of BMRN stock on 01/29/2021 at the average price of $82.79. The price of the stock has decreased by 2.09% since.

  • CEO Jean Jacques Bienaime sold 8,333 shares of BMRN stock on 01/27/2021 at the average price of $85.49. The price of the stock has decreased by 5.18% since.

Directors and Officers Recent Trades:

  • Director V Bryan Lawlis sold 7,500 shares of BMRN stock on 02/16/2021 at the average price of $87.41. The price of the stock has decreased by 7.26% since.

For the complete insider trading history of BMRN, click here

.This article first appeared on GuruFocus.